| INTRODUCTION
Periodontal ligament (PDL) is a highly specialized connective tissue that suspends individual teeth within the alveolar bone. PDL has several biological functions including tooth support, regulating tooth eruption, dissipating masticatory forces and facilitating the movement of teeth through the alveolar bone when under orthodontic force. 1 Periodontal disease is a chronic inflammatory disorder of the periodontium that affects 46% of the US population and may progress to tooth loss. 2 It is speculated that the enzymatic activity of oral pathogens and the ensuing host response erode PDL collagen and impair tooth support. 3 The extracellular matrix of PDL is comprised primarily of collagen types I (75%), III (20%) and V (5%). 4 Healthy PDL maintains the structural and biomechanical integrity of type I collagen and transmits occlusal stresses while undergoing rapid turnover. 5 Indeed, two defining features of PDL collagen are its notably high rate of turnover and its small fibril diameter in relation to other connective tissues. 6 Post-translational modifications determine the tissue-specific organization of collagen molecules and intermolecular cross-link formation, thereby defining the biomechanical properties of collagen fibers and connective tissue. 7 Indeed, it is becoming increasingly clear that unique tissue-specific modifications such as prolyl 3-hydroxylation (tendon and sclera), 8 lysyl 5-hydroxylation (bone, tendon, skin) 9 and glycosylation (bone, skin) 10, 11 can play essential roles in defining the structural and mechanical properties of specialized connective tissue. Tissue-specific regulation of these enzymatic modifications is essential and fundamental to tissue functionality.
The prolyl 3-hydroxylases (P3Hs) are members of a class of enzymes known as 2-oxoglutarate-dependent dioxygenases. The P3H family is composed of three isozymes (P3H1, P3H2 and P3H3) and two non-enzymatic proteins (CRTAP and SC65). The physiological significance of these proteins is underscored by the growing spectrum of disorders caused by mutations in their encoding human genes and genetically engineered mouse models. For example, LEPRE1 (P3H1) and LEPREL3 (CRTAP) mutations have been associated with osteogenesis imperfecta 12, 13 10 In PDL, lysyl hydroxylase-2, the enzyme responsible for cross-linking telopeptide lysine hydroxylation, and lysyl oxidase, the enzyme that catalyzes the conversion of crosslinking telopeptide (hydroxyl-) lysine to (hydroxyl-) lysine aldehyde are overexpressed in teeth under occlusal function. 1, 19 We speculate that the unique combination of type I collagen modifications or "molecular phenotype" customizes collagen matrices to function in tissue-specific environments.
PDL health depends on the capacity for type I collagen to sustain both rapid turnover and transmission of occlusal load. 5 
| Periodontal ligament isolation

| Transmission electron microscopy
Whole mandible was harvested from a C57Bl/6 mouse (n=1) killed Inc., Redding, CA, USA). Sections were cut perpendicular to PDL using a diamond ultra-knife at 65 nm to obtain cross-sections of PDL fibers. Contrasting was done with tannic acid 0.01% for 3 minutes at 60°C, uranyl acetate 2% for 30 minutes and then lead citrated for 10 seconds. Sections were examined with a Philips CM100 transmission electron microscopy (TEM; Eindhoven, Netherlands) and images were captured using an Olympus Morada camera (Münster, Germany).
Survey images at 4600× were obtained from the middle of the PDL apico-coronally and mesio-distally (10 images per mouse sample and 16 images per human sample). Regions where collagen fibers were sectioned transversely were imaged at 64 000× and 10 regions were chosen for analysis using Image J Software (National Institutes of Health, Baltimore, MD, USA). 
| Collagen extraction
Type I collagen was solubilized from human and mouse PDL by heat denaturation for 5 min at 95°C in Laemmli buffer (sodium dodecyl sulfate [SDS] extraction). SDS extraction was also used to extract collagens from mouse medial collateral ligament (MCL), skin and tail tendon as previously described. 23 Collagen α-chains were resolved by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with
Coomassie Blue R-250.
| Mass spectrometry
MS analysis of the hydroxylation and glycosylation content within collagen α-chains was performed as previously described. 24 Collagen α-chains were cut from SDS-PAGE gels and subjected to in-gel trypsin digestion. Electrospray MS was carried out on the tryptic pep- 
| RESULTS
| Transmission electron microscopy analysis of periodontal ligament collagens
Ultrastructural features of human and mouse PDL collagen were investigated by electron microscopy. The small sample size (n=1) was (Table 1 ). In contrast, the MCL phenocopied tendon post-translationally with a high occupancy of prolyl 3-hydroxylation at both these sites (Table 1) . PDL shares this site-specific lack of 3-hydroxyproline with skin and bone type I collagen. 18 Table 1 summarizes the prolyl-3-hydroxylation patterns found in type I collagen from PDL.
| Post-translational modifications of linear crosslinking lysine residues
The post-translational nature of the type I collagen linear cross-linking lysine residues was also compared between PDL, MCL, tendon and skin tissues. Using the same tryptic peptides that were used for the (GPP) n motif (Figure 2 ), the degree of hydroxylation on the α1(I) telopeptide cross-linking lysine was estimated. Table 1 summarizes the percentages of hydroxylation at the C-telopeptide cross-linking Lys across tissues. The high percentage of hydroxylysine at the telopeptide cross-linking site (~85%), suggests that PDL type I collagen is largely cross-linked using the hydroxylysine aldehyde cross-linking pathway. A similar cross-linking pathway is likely used for human PDL collagen (~50% Hyl) and mouse MCL collagen (~65% Hyl). Skin collagen is distinct from PDL in that it is solely cross-linked via the lysine aldehyde pathway. 27 The type I collagen helical cross-linking lysines (Lys87) were also investigated in PDL. In humans, the post-translational profile at Lys87 from both α-chains of type I collagen was fully glycosylated in PDL ( Figure 3 ). This finding is in agreement with what has previously been published for bovine PDL. 21 In the mouse, the post-translational profile of Lys87 was similar in PDL and skin. For example, in mouse PDL and skin, the α1(I) Lys87 residue was fully glycosylated with glucosylgalactosyl, and the α2(I) Lys87 residue had an identical proportion of lysine hydroxylation with little to no glycosylation (Table 2) 
| DISCUSSION
Our results indicate that, compared to other connective tissue sources, type I collagen from PDL has a unique post-translational phenotype.
For example, specific prolyl 3-hydroxylation substrate sites from the α1-chain of type I collagen, Pro707 and (GPP) n , which are highly modified in most ligaments and tendons from both mouse and human, are completely lacking in PDL tissue from both species. Another noteworthy difference between PDL and other ligaments was found in the highly conserved helical cross-linking Lys87 residue, which was F I G U R E 2 Collagen from PDL gives a distinct post-translational fingerprint from other ligaments. Representative SDS-PAGE of collagens extracted from PDL tissue. Human (n=1) and mouse (n=6) PDL were subjected to SDS extraction and resolved on 6% SDS-PAGE (A). Mass spectra of (GPP) n containing tryptic peptides from human and mouse PDL. Full scan spectra from liquid chromatography-mass spectrometry profiles of in-gel trypsin digests of α1(I) from human PDL (B) and mouse PDL (C). K*, Hyl; P*, 4Hyp; P#, 3Hyp; PDL, periodontal ligament; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis Hyl, hydroxylysine; 3Hyp, 3-hydroxyproline; MCL, medial collateral ligament; PDL, periodontal ligament.Percentage hydroxylation at the major 3Hyp sites and the C-telopeptide cross-linking lysine in type I collagen from PDL, MCL, tendon and skin. Percentages (mean±SD) were determined based on the ratio of the m/z peaks of each post-translational variant. ligaments. 1 Higher levels of modified Lys were identified in the Ctelopeptide cross-linking site of mouse (85%) than human (50%). This is likely the result of a general trend in higher levels of collagen modifications in mice compared to higher mammals 8, 18 ; however, potential differences in cross-linking cannot be ruled out. Overall, however, mouse and human PDL type I collagen displayed several cross-species collagen post-translational similarities.
Collagen post-translational modifications are fundamental to defining the structural properties of a tissue. The collagen superfamily is composed of at least 45 genes and gene translational products each with variably regulated post-translational modifications. Although this post-translational variability is still not fully understood, it is becoming increasingly evident for fibril-forming collagens that these modifications can influence covalent intermolecular cross-links that are fundamental to tissue function. 7 For example, the high degree of hydroxylation on the cross-linking telopeptide lysine of PDL collagen is comparable to the post-translational phenotype of load-bearing ligaments. In contrast, the lack of specific prolyl 3-hydroxylated substrate sites is identifiable with skin and bone collagen, which have relatively high rates of turnover. 5 It is therefore tempting to speculate that the unique post-translational phenotype of PDL type I collagen has evolved to generate a structure suited to function in an environment of load-bearing and rapid turnover. Cross-linking of PDL collagen fibrils enables the transmission of tensile stresses through PDL collagen fibrils during crown loading, and the high rate of PDL collagen turnover rebuilds these load-bearing elements. However, when disease processes promote collagen degradation and/or impair turnover, periodontal stress transmission and tooth attachment are expected to be affected.
The function of the evolutionarily conserved residue, 3-hydroxyproline, in collagen biology is still unclear. However, tissues such as tendon, sclera and ligament have been shown to exhibit unusually high levels of P3H2-catalyzed prolyl 3-hydroxylations in their fibrillar collagens. Furthermore, P3H2 appears to be developmentally regulated, as the level of substrate modification has been shown to increase in older animals and tissues. 23, 28 Indeed, the P3H2-catalyzed prolyl 3-hydroxylation of the (GPP) n motif has an apparent association with tendon-like tissue, which needs to grow linearly with growing skeleton, yet turns over slowly during adulthood. 23, 25 This developmental regulation (and requirement for prolyl 3-hydroxylation), which appears to be tissue-specific to tendons and ligaments, may be functionally distinct from PDL. Type I collagen production is epigenetically controlled in PDL, with collagen expression decreasing with age. 29 Furthermore, PDL-derived cells have been shown to up-and Human PDL α1(I) Mouse PDL α1(I) ; however, PDL has a significantly higher level of immature cross-links compared to skin. 9, 27 This distinct pattern of cross-linking potentially imparts the high tensile strength and capacity for rapid turnover to PDL.
The combination of rapid turnover and immature collagen crosslinks could help to explain the smaller diameter of PDL collagen fibrils.
Collagen fibril diameter varies between species, tissues, tissue sites and age. 35 Previous studies have shown that the PDL fibril diameters in both rodent and human teeth are relatively small, ranging from ~45 to 55 nm. 36, 37 Our TEM data support that collagen fibrils have comparable diameters in mouse and human PDL (~57 nm). Tissues that are under high tension or compressive stress, such as PDL, typically have smaller diameter collagen fibrils with more interfibrillar cross-links, which facilitate the return to the tissue's original form. Conversely, tissues that experience high tensile strength, such as tendon, have larger diameter collagen fibrils and more intrafibrillar cross-links. 35 Indeed, tendon and ligament collagen fibrils have been shown to attain diameters as large as 300 nm. 38 Previously, only limited data were available to compare PDL collagen post-translational modification in different species. The evolutionary conserved similarities between human and murine PDL collagen post-translational modifications and fibril diameter presented here support the use of murine models for future PDL collagen studies. The development of this model for human PDL collagen enables further focus on how specific components of post-translational pathways contribute to cross-link formation, and development of the PDL collagen's capacity for load-bearing and high turnover. Thus, future study may define key steps in PDL collagen formation that must be replicated in regenerative treatments to re-establish a healthy PDL. Furthermore, we propose that the unique tissue-specific characteristics revealed in the current study may predispose the PDL to increased susceptibility to microbial and inflammatory proteases. Mouse models could be useful for investigating how periodontal disease affects collagen fibrillogenesis, and may lead to a better understanding of susceptibility of the PDL collagen structure to specific microbial and host proteases. α2(I) 32±4% 68±4% --GG-Hyl, glucosyl-galactosyl-hydroxylysine; G-Hyl, galactosyl-hydroxylysine; Hyl, hydroxylysine; 3Hyp, 3-hydroxyproline; Lys, lysine; MCL, medial collateral ligament; PDL, periodontal ligament. Modifications on Lys87 from both α-chains of type I collagen in human PDL and mouse PDL, MCL, tendon, and skin were measured using mass spectrometry. Lys modifications include unmodified Lys, Hyl, G-Hyl and GG-Hyl. Percentages (mean±SD) were determined based on the ratio the m/z peaks of each posttranslational variant.
